OTCM
GEBHY
Market cap11bUSD
Jun 18, Last price
2.88USD
1D
2.31%
1Q
-13.66%
Jan 2017
-67.70%
Name
Genting Bhd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Genting Berhad, a diversified investment holding company established in 1965 and headquartered in Kuala Lumpur, Malaysia, operates a broad spectrum of businesses both domestically and across international markets. Its extensive portfolio encompasses various industries, including leisure and hospitality, palm oil cultivation, power generation, oil and gas exploration, property development and management, as well as life sciences and biotechnology ventures. The company's Leisure & Hospitality division oversees a wide array of offerings, such as gaming establishments, hotels, food and beverage outlets, theme parks, retail spaces, entertainment venues, tourist attractions, and travel-related services. This segment is also responsible for the construction and operation of integrated resorts and provides various ancillary support functions. In the agricultural sector, its Plantation segment manages oil palm estates and conducts palm oil milling alongside related processing activities. The Power division is dedicated to generating and distributing electrical energy, while the Property segment focuses on real estate investment and development projects. Within the energy sector, the Oil & Gas unit is engaged in the exploration, development, and production of crude oil and natural gas resources. Beyond these core operations, Genting extends its services to include offshore financing, specialized advisory, technical, and administrative support for oil and gas companies, and comprehensive risk and insurance management consultancy. The company also participates in capital markets through the issuance of private debt securities and commercializes its proprietary intellectual property rights. Further diversifying its activities, Genting manufactures and distributes biodiesel, processes fresh fruit bunches, and offers a range of project management, technical, and general management services. Its life sciences initiatives involve significant research and development efforts in genetic analysis and sequencing, aiming to create platforms for the early diagnosis and treatment of conditions such as Alzheimer's and other neurodegenerative diseases. This includes the collection, analysis, and rigorous testing of biological specimens and data for scientific research and evaluation purposes. Additionally, the company provides crucial information technology services tailored for the gaming and resort industries, alongside international sales and marketing solutions, and various corporate support functions.
Valuation
Title MYR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||